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Background
Here we report a case of a child who developed Henoch–
Schönlein purpura (HSP) after administration of valproic
acid.
Case report
A 14-year-old male was admitted with a five months his-
tory of recurrent purpuric papules on his buttocks and
lower limbs lasting up to four days with a burning sensa-
tion. The patient had a 10 year medical history of epileptic
absences treated with valproic acid 300 mg daily before
the initiation of purpura. Laboratory screening for cuta-
neous vasculitis was unremarkable including full blood
count with differential, liver function tests, renal and coa-
gulation profile. Results of testing for celiac and thyroid
antibodies were negative . Immunological testing for anti-
DNA antibodies, IgG, IgA, IgE, IgM, plasma levels of C3
and C4 factors were also negative. Plasma levels of valproic
acid were 27,2 μg/ ml (therapeutic serum concentrations
range from 50 to 100μg/ml). A skin biopsy showed a mas-
sive inflammatory infiltrate in the dermis extravasation of
neutrophils and erythrocytes and deposition of fibrin.
Direct immunofluorescence demonstrated deposits of IgA
in the vascular wall that confirmed the diagnosis of
Henoch–Schönlein purpura. On discontinuation of
valproate, the child was fully recovered from purpura
seven days after the withdrawal of the drug. The child was
challenged via hyperventilation for seizures with negative
results. He was followed up for more than one year with
no recurrence of the rash or epilepsy.
Conclusion
This is the first reported case of Henoch–Schönlein pur-
pura induced by valproic acid. Physicians should be
aware of the range of severity of Henoch–Schönlein
purpura and discontinue the drug Sodium valproate
should be added to the list of drugs that may cause
Henoch–Schönlein purpura.
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